{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-164555","form_type":"8-K","ticker":"AGIO","cik":"0001439222","company_name":"AGIOS PHARMACEUTICALS, INC.","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.436319+00:00","generated_at":"2026-06-01T03:20:47.371986+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Agios shareholders elect four Class II directors, approve say-on-pay, ratify auditor at 2024 annual meeting","bullets":["Elected Kaye Foster (45.8M for, 5.3M withheld), Maykin Ho (46.7M for, 4.4M withheld), Jeffrey Capello (47.8M for, 3.3M withheld), Catherine Owen (45.6M for, 5.5M withheld) as Class II directors.","Advisory vote on named executive officer compensation approved: 48.0M for, 3.1M against, 13,404 abstaining.","Ratified PricewaterhouseCoopers LLP as independent auditor: 52.3M for, 70,843 against, 2,396 abstaining."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-164555","json":"https://secwatch.observer/filing/0001193125-24-164555.json","markdown":"https://secwatch.observer/filing/0001193125-24-164555.md","text":"https://secwatch.observer/filing/0001193125-24-164555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439222/000119312524164555/0001193125-24-164555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439222/000119312524164555/d645924d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:20:47.371986+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}